Headache News and Research

Latest Headache News and Research

FDA approves FluLaval

The U.S. Food and Drug Administration (FDA) today approved FluLaval, an influenza vaccine to immunize people 18 years of age and older against the disease caused by strains of influenza virus judged likely to cause seasonal flu in the Northern Hemisphere in 2006-2007.

5 Oct 2006

Rivastigmine improves memory loss for traumatic brain injury patients

Traumatic brain injury patients with moderate to severe memory loss improved their memories while taking the drug rivastigmine, according to a study published in the September 12, 2006, issue of Neurology.

12 Sep 2006

Zolmitriptan nasal spray may be safe and effective in treating painful cluster headaches

Zolmitriptan nasal spray, used to treat migraine headaches, also may be safe and effective in treating painful cluster headaches, according to an article posted online today that will appear in the November 2006 print issue of Archives of Neurology.

12 Sep 2006

New drug sorts out premature ejaculation

According the American Urological Association, premature ejaculation affects about 20% of males in the U.S. aged 18-59.

11 Sep 2006

SSRI's developed for premature ejaculation, safe and effective

A selective serotonin reuptake inhibitor (SSRI) developed specifically for the treatment of premature ejaculation is safe and effective for men severely affected by the condition, according to an Article in this week's issue of The Lancet.

7 Sep 2006

Botox offers an additional tool in preventing the formation of bad scars

Mayo Clinic researchers have found that treating a facial wound in the early healing phase with botulinum toxin (Botox) improves the appearance of a scar later.

8 Aug 2006

Lassa fever reported in Germany

German health authorities have reported to WHO an imported case of Lassa fever, confirmed by laboratory tests at the Bernhard-Nocht-Institute of Tropical Medicine, Hamburg, Germany.

25 Jul 2006

FDA approves Elaprase (idursulfase) for Hunter syndrome

The U.S. Food and Drug Administration (FDA) has approved Elaprase (idursulfase), the first product for the treatment of Hunter syndrome (Mucopolysaccharidosis II, or MPS II).

25 Jul 2006

Matchstick-sized contraceptive implant that lasts for three years

The Food and Drug Administration in the U.S. has given approval for a new contraceptive which will protect women from pregnancy for as long as three years.

20 Jul 2006

Drugs given to stop nausea and vomiting after surgery help only a few people

Between 10 - 28% of people benefit from taking an anti-emetic drug to prevent nausea or vomiting after surgery - this means that if everyone was given the drug the majority of patients would be exposed to the risk of side-effects without gaining any benefit.

19 Jul 2006

Neuraminidase inhibitors for preventing and treating influenza in healthy adults

A class of drugs commonly used to treat typical influenza symptoms such as fever, headache and cough do not prevent people from becoming infected with the flu virus.

19 Jul 2006

Conjugate vaccines for preventing meningococcal C meningitis and septicaemia

A new systematic review suggests that a certain kind of vaccine may help to protect babies and small children from a devastating killer: meningococcal meningitis.

19 Jul 2006

Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems

Expectant mothers may be able to prevent potentially serious medical problems in themselves and their babies simply by boosting their daily calcium intake, says a new systematic review.

19 Jul 2006

Drugs for preventing postoperative nausea and vomiting

Patients coming out of anesthesia after surgery may experience nausea or vomiting, and are frequently given drugs to prevent this. But the majority of patients won't benefit from these drugs, according to a large new review of studies.

19 Jul 2006

77 die from rare tropical disease on island paradise

Travellers to an exotic island in the Indian Ocean have been issued with warnings against a rare tropical disease.

17 Jul 2006

FDA approves Atripla for the treatment of HIV-1 infection in adults

Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.

13 Jul 2006